Search

everythinglearnresearchcommunity

for

Search:↓

Careful histologic examination is crucial to differentiate types of bullous lesions in cutaneous lupus erythematosus.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A woman with discoid lupus improved with treatment after being misdiagnosed with a different hair loss condition.

Personalized treatment and teamwork among doctors can reduce chemotherapy side effects and improve patient outcomes.

Controlled microflora in animals delays immune cell maturation and affects immunity.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Different connective tissue disorders have unique symptoms and treatments, with varying outcomes and often require ongoing care from a specialist.

Pulsed dye laser treatment was effective for a skin condition resistant to other treatments.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Poly-L-lactic acid injections can cause hair loss and skin issues.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Both treatments are safe and effective, but anthralin may work better for some patients.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

The thyroid nodule was benign, and surgery was successful with a smooth recovery.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.